A fter recognizing antigen on stimulatory dendritic cells, naive CD4
+ or CD8 + T cells proliferate and differentiate into effector cells capable of migrating to peripheral tissues and of performing protective functions. Once the antigen has been eliminated, some of the primed T cells persist as circulating central memory T cells or effector memory T cells that can provide enhanced responses after re-exposure to their cognate antigen in secondary lymphoid organs or peripheral tissues, respectively 1 . It is now well established that some of the T cells that enter tissues, in particular the CD8 + effector T cells that enter epithelial and mucosal barriers, remain in the tissue and form a pool of resident memory T cells that can promptly respond and provide protective immunity independently of T cells recruited from blood 2, 3 . T cell effector function is mediated largely through the release of pro-inflammatory cytokines. Helper T cells that produce IL-17 (T H 17 cells) can induce the recruitment of neutrophils and trigger the production of pro-inflammatory cytokines and chemokines by a broad range of cellular targets. Although these effector functions confer on T H 17 cells the ability to provide protection against certain extracellular bacteria and fungi, a deregulated T H 17 cell response can induce severe tissue damage and chronic inflammation. Several mechanisms have evolved to limit the immune response to pathogens; for example, IL-10 is a potent anti-inflammatory cytokine that has a non-redundant role in restraining inflammatory responses in vivo and thereby prevents damage to the host 4 . In addition to upregulating IL-10, activated effector T cells can upregulate the expression of various inhibitory receptors that limit co-stimulatory signals to dampen the immune response [5] [6] [7] . For example, the costimulatory receptor CTLA-4 can inhibit the activation of T cells intrinsically by outcompeting the co-stimulatory receptor CD28 for binding to the co-stimulatory molecules CD80 and CD86, while engagement of the co-inhibitory receptor PD-1 by its ligands (PD-L1 or PD-L2) triggers an inhibitory signal.
IL-10 production is a characteristic of human T H 17 cells that have been primed by Staphylococcus aureus but not of T H 17 cells that have been primed by Candida albicans, which instead co-express IL-17A
and interferon-γ (IFN-γ ) 8 . Interestingly, the production of IL-17A and IL-10 by S. aureus-specific T H 17 cells is temporally regulated, with IL-17A being produced within hours of antigenic stimulation and IL-10 being produced only by 3-5 d after triggering of the T cell antigen receptor. Those results led us to hypothesize that antigenic stimulation of memory T cells might set in motion a post-activation gene-expression program that can reveal further T cell heterogeneity relevant for in vivo regulation of the immune response.
Results

IL-10 production is a property of a human T H 17 cell subset.
A large number of human T H 17 clones were isolated from CCR6 + CCR4 + CXCR3 -memory T cells or from IL-17A-producing CCR6 + CXCR3 -T cells ( Supplementary Fig. 1a ). Cytokine production was measured in T cell clones in the resting state (at day 0; called 'day 0 cells' here) and in the recently activated state (at day 5 following re-stimulation with antibody to the invariant signaling protein CD3 (anti-CD3) and anti-CD28; called 'day 5 cells' here). On day 0, all T H 17 clones produced IL-17A but no IL-10 ( Fig. 1a,b) . However, on day 5 following re-stimulation, the T H 17 clones showed a heterogeneous pattern of cytokine production. About 25% of the clones acquired the ability to produce IL-10, concomitant with downregulation of IL-17A expression (called 'T H 17-IL-10 + cells' here), while the remaining clones downregulated IL-17A expression but did not acquire the ability to produce IL-10 (called 'T H 17-IL-10 -cells' here) (Fig. 1a,b) . When reverted to a resting state (at day 21 following restimulation), the clones re-acquired the ability to produce IL-17A and, in the case of T H 17-IL-10 + clones, lost the ability to produce IL-10 ( Fig. 1b) . Notably, production of IL-10 was observed over repeated rounds of stimulation ( Fig. 1b) .
To investigate the mechanisms underlying the delayed kinetics of IL-10 production in day 5 (activated) T H 17 cells, we evaluated histone modifications at the IL10 transcriptional start site (TSS) by chromatin immunoprecipitation (ChIP) and measured expression of the gene encoding c-MAF (MAF), a transcription factor that regulates IL10 transcription in several immune cells [9] [10] [11] [12] . In day 0 (resting) T H 17-IL-10 + and T H 17-IL-10 -cells, the IL10 TSS was associated with a large abundance of the histone modification H3K27me3, indicative of repressed chromatin (Fig. 2a) . In contrast, in day 5 (activated) T H 17-IL-10 + cells, but not in their T H 17-IL-10 -counterparts, the IL10 TSS was associated with abundant H3K4me3, indicative of transcriptionally active chromatin (Fig. 2a) . Day 0 T H 17 cells exhibited low expression of MAF mRNA (both isoform a and isoform b) and c-MAF protein, but the amount of c-MAF selectively increased in day 5 T H 17-IL-10 + cells (Fig. 2b-d) . Furthermore, binding of c-MAF to a previously characterized c-MAF-binding site (the MAF-responsive element MARE-2) on the IL10 promoter 11, 13 was significantly greater in day 5 T H 17-IL-10 + cells than in day 5 T H 17-IL-10 -cells (Fig. 2e) . Collectively, these data indicated that subsequent to an initial antigenic stimulation, a subset of human memory T H 17 cells underwent changes in chromatin conformation that were accompanied by upregulation of the expression of c-MAF (and possibly other transcription factors) and the ability to produce the anti-inflammatory cytokine IL-10.
M1 and M2 polarization by T H 17-IL-10
-and T H 17-IL-10 + cells.
Since T H 17-IL-10
+ cells produce an array of cytokines different from that produced by T H 17-IL-10 -cells, we evaluated their capacity to polarize monocytes toward developing into M1 macrophages, which produce pro-inflammatory cytokines and nitrogen radicals for increased anti-microbial activity, or M2 macrophages, which inhibit the production of inflammatory mediators and promote tissue homeostasis and repair 14, 15 . Monocytes co-cultured with day 5 T H 17-IL-10 + cells rapidly upregulated expression of the M2 macrophage-associated markers CD163 and CD206, while the same cells co-cultured with day 5 T H 17-IL-10 -cells upregulated expression of the M1 macrophage-associated markers CD40 and HLA-DR and produced large amounts of the cytokines TNF and IL-6 ( Fig. 3a-c) . In addition, monocytes cultured in the presence of conditioned supernatants from day 5 T H 17-IL-10 -cells or those from T H 17-IL-10 + cells differentiated into macrophages with constitutive gene expression and lipopolysaccharide (LPS)-induced gene expression comparable to that of macrophages differentiated through the use of M1 macrophage-inducing cytokines or M2 macrophage-inducing cytokines, respectively (Fig. 3d) . M2-like macrophages induced by T H 17-IL-10 + cells expressed genes -cells were able to promote M2 differentiation and M1 differentiation, respectively, which indicated that they might modulate the immunological microenvironment differentially.
Regulatory or pro-inflammatory program in T H 17 cell subsets.
To investigate the differences between the two T H 17 cell subsets on a genome-wide scale, we performed RNA-based next-generation sequencing (RNA-seq) on day 0 and day 5 (before and after stimulation for 2 h with anti-CD3 and anti-CD28). With the heuristic expression cut-off of a fragments per kilobase of exon per million fragments mapped (FPKM) value of 2, we found that 295 genes were expressed differentially by day 0 T H 17-IL-10 + clones relative to their expression by day 0 T H 17-IL-10 -clones (a change in expression of twofold or more), while this number increased to 1,185 for the same comparison of day 5 T H 17-IL-10 + clones versus day 5 T H 17-IL-10 -clones (Fig. 4a,b) . The set of genes expressed more abundantly in T H 17-IL-10 + cells showed enrichment for those encoding molecules involved in biological processes involving regulation of immune responses, whereas the set of genes expressed more abundantly in T H 17-IL-10 -cells showed enrichment for those encoding molecules involved in processes linked to stress, external cues and chemotactic signals (P < 1 × 10 -5 (hypergeometric distribution); Supplementary Fig. 2a) .
A further hint that gene regulation in T H 17-IL-10 + clones was different from that in T H 17-IL-10 -clones was provided by the analysis of lncRNAs, non-protein-coding regulatory transcripts that are expressed differentially in functionally distinct T cell subsets 18, 19 . The number of lncRNAs expressed differentially by day 0 T H 17-IL-10 + clones relative to their expression by day 0 T H 17-IL-10 -clones was limited to 40, but this number increased to > 200 for the corresponding comparison of day 5 clones (Fig. 4c) . Genes proximal to lncRNAs found in T H 17-IL-10 -clones encoded products involved in the differentiation and activation of T cells, while genes proximal to lncRNAs found in the T H 17-IL-10 + clones encoded products involved mainly in positive and negative modulation of the immune response and cell death ( Supplementary Fig. 2b ).
The differential expression of selected genes encoding regulatory and pro-inflammatory molecules was validated by qPCR (Fig. 4d) . In addition to expressing genes encoding IL-10 and c-MAF, T H 17-IL-10 + clones expressed genes encoding regulatory molecules, such as TGFB1, CTLA4 and PDCD1, as well as IKZF3, which encodes the transcription factor AIOLOS that controls IL-10 expression 20 , and genes encoding molecules involved in the function of regulatory T cells (T reg cells) and regulation of the Each symbol represents an individual T cell clone pool (n = 12). e, ChIP analysis of the binding of c-MAF to MARE-1 and MARE-2 in the IL10 promoter, as well as to a developmentally repressed locus (Ctrl-1) and a pericentromeric DNA repeat region (Ctrl-2) (negative controls). Each symbol represents an individual T cell clone pool (n = 10). *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 (ratio paired t-test). Data are representative of at least three independent experiments (mean + 95% confidence interval (CI) in a,d,e; mean + s.e.m. in b).
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T H 17 cell-T reg cell balance, such as BACH2 (which encodes the transcriptional repressor BACH2) 21 , LRRC32 (which encodes the regulatory glycoprotein GARP) 22, 23 , LGMN (which encodes the cysteine protease legumain) 24 and P2RX7 (which encodes the purogenic receptor P2X7) 25 . In addition, T H 17-IL-10 + cells expressed genes encoding effector molecules, such as GZMA (which encodes granzyme A), LTB (which encodes lymphotoxin-β ), NKG7 (which encodes the granule membrane protein NKG7) and PTGDS (which encodes prostaglandin D synthase + cells had abundant expression of CD69 (which encodes the activation marker CD69), CXCR6 (which encodes the chemokine receptor CXCR6), CCR9 (which encodes the chemokine receptor CCR9) and ITGB7 (which encodes the integrin β 7 ), as well as DUSP6 (which encodes the phosphatase DUSP6) and PRDM1 (which encodes the transcription factor BLIMP-1), whose expression has been associated with tissue-resident memory T cells (T RM cells) 3, 26, 27 . Conversely, T H 17-IL-10 -cells had high expression of CCR7, which drives T cells from tissues to lymph nodes via afferent lymphatics 28 . The differential expression of CTLA-4, PD-1, CD25, CD69, CXCR6 and CCR7 in day 5 T H 17-IL-10 + cells relative to that in day 5 T H 17-IL-10 -cells was confirmed at the protein level ( Supplementary Fig. 3a,b) . Although several genes that had high expression in T H 17-IL-10 + cells encode molecules that have been associated with T reg cell function, we did not detect any difference between T H 17-IL-10 + cells and T H 17-IL-10 -cells in their expression of the transcription factor FOXP3 ( Supplementary Fig. 3b ). Of note, T H 17-IL-10 + cell populations expanded less when stimulated with anti-CD3 and anti-CD28 than did their T H 17-IL-10 -counterparts ( Supplementary Fig. 3c ). Together the findings reported above indicated a previously unknown level of substantial heterogeneity in T H 17 cells that became evident when the cells were in a 
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recently activated state, with one subset acquiring anti-inflammatory, regulatory and tissue-residency properties and a second subset acquiring pro-inflammatory and recirculating properties.
T H 17 cell-associated genes are modulated by IL-27 and IL-1β. IL-1β induces the production of IFN-γ and inhibits the production of IL-10 in T H 17 cells, while TGF-β and IL-27 induce the expression of IL-10 and act together with the transcription factor AHR ('aryl hydrocarbon receptor') to promote the differentiation of T regulatory type 1 (Tr1) cells 8, 11 . Activation in the presence of IL-1β induced the downregulation of IL10 and of genes encoding immunoregulatory and tissue-residency molecules (CTLA4, PTGDS, TGFB1 and CXCR6) in T H 17-IL-10
+ cells, while expression of IL23R, CD25 and CCR7 was upregulated, at the level of both mRNA and Ctrl IL-1β
Ctrl IL-1β
Ctrl IL-1β -). *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 (ratio paired t-test).
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NATurE IMMuNOLOgy IL-10 production (Fig. 5d ). Together these data indicated that the expression of genes associated with T H 17-IL-10 + cells and those associated with T H 17-IL-10 -cells were regulated, at least in part, differentially by IL-1β and IL-27.
T H 17 cell transcriptional profiles and disease states. To validate in vivo the gene signatures identified for the two types of T H 17 cells, we compared their transcriptional profiles with publicly available transcriptomic datasets from two cohorts of patients with T H 17 cell-mediated autoimmune diseases. Gene-set-enrichment analysis of transcriptomic datasets from ileal biopsies of patients with Crohn's disease (GSE57945) 29 and healthy control subjects showed a significant association with the T H 17-IL-10 -cell signature, which increased with severity of inflammation (assessed on the basis of histology) (P < 0.05 (familywise error rate); Supplementary Fig. 4a) . Interestingly, MAF expression in ileal biopsies of patients with Crohn's disease was negatively correlated with the degree of intestinal inflammation and ulceration ( Supplementary Fig. 4c ). Similar analysis of transcriptomic datasets of peripheral blood mononuclear cells (PBMCs) obtained from patients with juvenile rheumatoid arthritis (GSE1402) 30 and healthy control subjects revealed a dominant gene-expression signature associated with T H 17-IL-10 + cells in the latter, whereas gene signatures associated with T H 17-IL-10 -cells were identified in PBMCs and, in particular, synovial-fluid mononuclear cells from the patients with rheumatoid arthritis (Supplementary Fig. 4b ). These data suggested that T H 17-IL-10 (Fig. 6a) . In contrast, c-MAF bound extensively to DNA in day 5 T H 17-IL-10 + cells (6,778 peaks). Analysis of the immunoprecipitated sequences for DNA-binding motifs revealed that the c-MAF site was the transcription factorbinding site with the top score ( Supplementary Fig. 5a ), in support of the ChIP-seq quality. In addition, the analysis recognized binding motifs for proteins known to interact with c-MAF (AP-1, ETS and NFAT) and proteins previously not known to do so (RUNX and 
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TCF), which potentially bind with c-MAF to chromatin in a cooperative manner. We then assigned each c-MAF peak to the genes located within 185 kilobases (kb), a median size of genomic interaction domains 31 . 2,833 c-MAF peaks were assigned to one gene, while 3,275 c-MAF peaks were assigned to two genes; this identified a total of 5,078 genes, which represented about 21% of all transcripts identified in day 5 T H 17-IL-10 + cells. Gene-ontology analysis of the associated genes revealed that c-MAF bound in the vicinity of genes encoding molecules involved in the regulation of lymphocyte activation and in the immune response ( Supplementary Fig. 5b ). Most of the validated genes encoding molecules associated with immunoregulation and tissue residency (for example, IL10, CTLA4, PDCD1, IKZF3, PRDM1, CD69 and CXCR6) had one or more c-MAF peaks within the genomic window analyzed (Supplementary Table  2 and Supplementary Fig. 6 ). By matching the genomic c-MAFbinding pattern with the transcriptional profile, we found that about 50% (584 of 1,185) of the genes expressed differentially by day 5 T H 17-IL-10
+ cells relative to their expression by T H 17-IL-10 -cells were associated with a c-MAF peak, while only 5.4% (16 of 295) of the genes expressed differentially in the corresponding comparison of day 0 cells were associated with a c-MAF peak (Fig. 6b) . Among the 584 genes associated with a c-MAF peak, 362 had higher expression in day 5 T H 17-IL-10 + cells, in which c-MAF protein was more abundant and extensively bound chromatin. However, the remaining 222 genes had higher expression in day 5 T H 17-IL-10 -cells (Fig. 6b) . Analysis of the immunoprecipitated sequences revealed enrichment for ETS-binding sites that flanked c-MAF peaks (within a window of 250 base pairs upstream or downstream) in the vicinity of genes with higher expression in T H 17-IL-10 + cells but not in the vicinity of genes with higher expression in T H 17-IL-10 -cells (Fig. 6c) .
Most (87.1%) of the c-MAF-binding sites in day 5 T H 17-IL-10
+ cells were located outside of gene promoters (Fig. 6d) . To investigate the possibility that these sites might represent enhancers, we performed ChIP analysis targeting histone modifications (such as H3K4me1, H3K4me3 and H3K27ac) associated with enhancer elements in a subset of c-MAF-bound regions. All the regions assessed by ChIP-qPCR were associated with an abundance of H3K4me1 and little H3K4me3 (Fig. 6e) , characteristic of enhancer regions 32, 33 . In this context, c-MAF exploited a pre-existing chromatin landscape, since these putative enhancers were present in both day 0 T H 17-IL-10 + cells and day 5 T H 17-IL-10 + cells. Moreover, ChIP-seq analysis of H3K27ac in day 0 and day 5 T H 17-IL-10 + cells demonstrated that c-MAF bound to active chromatin regions and that the abundance of H3K27ac in these regions was maximal in the day 5 cells (Fig. 6f) . Through this analysis, we also identified a previously unknown putative enhancer about 12 kb upstream the IL10 TSS 
(ratio paired t-test (a), paired t-test (b) or Wilcoxon matched-pairs signed-rank test (c)).
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that was conserved between humans and mice 34 ( Supplementary  Fig. 5c,d) . Furthermore, the activation status of this enhancer, as monitored by the H3K27ac and H3K27me3 modifications 35 , reflected IL10 expression in T H 17-IL-10 + cells (Supplementary Fig.  5e ). Collectively, these data indicated that c-MAF, by binding to putative enhancers, modulated the immunoregulatory and tissueresidency transcriptional program in recently activated T H 17-IL-10 + cells, acting mostly as a transcriptional co-activator but also acting as a transcriptional co-repressor in a context-dependent manner. (Fig. 7a) resulted in significant reduction in the expression of IL10 mRNA and IL-10 protein (Fig. 7b) . Global RNA-seq analysis of cells depleted of c-MAF showed that T H 17-IL-10 + cell-associated genes and T H 17-IL-10 -cell-associated genes segregated in two groups (Fig. 7c, left) that were downregulated and upregulated, respectively (Fig. 7c, right) . These data showed that c-MAF was essential for the transcription of some T H 17-IL-10 + cell-associated genes (27 genes; 24 downregulated and 3 upregulated, with a change in expression of 2-fold or more), including genes encoding relevant immunoregulatory and tissueresidency molecules, such as IL10, LGMN, LRRC32 and CCR9, and that it modulated the expression of a consistent proportion of the transcriptional program in day 5 T H 17-IL-10 + cells (110 genes; 84 downregulated and 26 upregulated, with a change in expression of 1.33-fold or more). In addition, we used qPCR to measure the expression of selected T H 17-IL-10 + cell-and T H 17-IL-10 -cellassociated genes in T H 17-IL-10 + cells depleted of c-MAF through the use of two independent short hairpin RNAs (shRNAs). After knockdown of c-MAF, the expression of most of the T H 17-IL-10 + cell-associated genes assessed was impaired, including genes that did not fulfill the selection criteria applied to the RNA-seq analysis, while transcription of some T H 17-IL-10 -cell-associated genes was upregulated (Fig. 7d) .
We next sought to determine whether the selected set of genes associated with T H 17-IL-10 + cells or T H 17-IL-10 -cells would be affected by ectopic expression of c-MAF in T H 17-IL-10 -cells. Overexpression of the isoform c-MAF-b led to a modest upregulation of IL-10 production, but overexpression of the isoform c-MAFa did not ( Supplementary Fig. 7a,b) . The different outcomes for c-MAF-a and c-MAF-b might have resulted from differences in protein levels or stability or interaction with dimerization partners. The addition of IL-27 increased the production of IL-10 in T H 17-IL-10 -cells overexpressing c-MAF-b ( Supplementary Fig. 7c ), which suggested that these were able to act in synergy in the induction of IL-10 expression. Other T H 17-IL-10 + cell-associated genes, such as LGMN, SLC7A8 and CXCR6, were also upregulated after overexpression of c-MAF-a or c-MAF-b, while other genes associated with T H 17-IL-10 -cells, such as IFNG, IL22, CSF2 and IL12RB2, were downregulated in those conditions, at the level of both mRNA and protein ( Supplementary Fig. 7e,f) .
Overall, the analyses reported above indicated that c-MAF was largely needed to set an immunoregulatory and tissue-residency Fig. 8a ). Furthermore, our data indicating that c-MAF bound to a set of pre-existing enhancers in day 5 T H 17-IL-10 + cells suggested that it lacks 'pioneering factor' activity. Therefore, forced expression of c-MAF was not itself sufficient to overcome the steric hindrance imposed by chromatin in T H 17-IL-10 -cells. DNA motif-enrichment analysis of subset-specific H3K27ac-positive regions (Supplementary Fig. 8b ) highlighted the possibility that the antagonistic expression of several transcription-factor pairs in day 5 (activated) T H 17-IL-10 + and T H 17-IL-10 -cells might regulate the transcriptional programs of immunoregulatory and proinflammatory T H 17 cells (Supplementary Fig. 8c-e) . Indeed, the lack of c-MAF binding might have also resulted from high expression of FOS and FOSB (which encode transcription factors of the FOS family) in day 5 T H 17-IL-10 -cells (Supplementary Fig. 8e ).The transcription factors c-MAF and FOS can each form heterodimers with the transcription factor JUN 36, 37 and have partially overlapping DNA-binding consensus motifs ( Supplementary Fig. 8d ), which suggests that they might compete for dimerization partners and binding to the same genomic loci. Finally, c-MAF might need to act together with other transcription factors for optimal gene expression; the reduced expression of the transcription factor-encoding genes IKZF3 and BATF in day 5 T H 17-IL-10 -cells ( Supplementary  Fig. 8e ) might explain the finding that c-MAF was not sufficient to fully convert them into T H 17-IL-10 + cells.
Discussion
Circulating memory T cells are recruited to inflamed tissues where, after recognizing antigen, they rapidly produce inflammatory cytokines such as IFN-γ and IL-17. Published in vivo studies of mice have shown that this initial stimulation leads to dynamic changes that modulate the capacity of the T cell to respond to further antigenic stimulation 38 . In this study, we used an in vitro system that mimics the temporally distinct phases of T cell activation to reveal a previously unknown level of heterogeneity in human T H 17 cells that became evident when recently activated cells responded to a second antigenic stimulation. One T H 17 cell subset maintained proinflammatory activity and acquired recirculating properties, while another subset acquired anti-inflammatory, immunoregulatory and tissue-residency properties. The latter transcriptional program was substantially modulated by upregulation of the expression of c-MAF, which bound to a large number of non-promoter regions with enhancer-like features, acting as transcriptional co-activator or co-repressor in a context-dependent manner.
The distinctive feature of the immunoregulatory T H 17 cells was their ability to produce IL-10, a potent anti-inflammatory cytokine that restrains inflammatory responses and thus prevents damage to the host 4 . Indeed, Il10-deficient mice develop spontaneous intestinal inflammation, and loss-of-function mutations in the IL10 receptor lead to infant-onset inflammatory bowel disease in humans 39, 40 . It is interesting to compare and contrast the immediate inflammatory response, characterized by the production of IL-17A that occurs a few hours after antigenic stimulation, with the late anti-inflammatory response characterized by the production of IL-10. Published studies have shown that in human IL-10-producing T H 1 cells, the IL10 locus is highly methylated and these cells lack memory of IL-10 expression 41 . Our study has extended those findings by showing that in resting T H 17 cells, the IL10 TSS was associated with high levels of H3K27me3, indicative of repressed chromatin. However, we found that immunoregulatory T H 17 cells maintained memory of IL-10 expression, which correlated with a selective upregulation of c-MAF expression. Conversely, the lack of IL-10 production by pro-inflammatory T H 17 cells was associated with the inability of these cells to upregulate c-MAF expression after being stimulated. Recently activated T H 17-IL-10 + cells differ from the T H 17 cell-derived Tr1-like cells ('ex-T H 17' cells) that have been described 42 , as they set in motion a temporally defined immunoregulatory program that is independent of AHR's transcriptional Articles NATurE IMMuNOLOgy activity and at the end of which the cells recover their original ability to produce IL-17A.
An intriguing finding of our study was that recently activated T H 17-IL-10 + cells acquired markers characteristic of T RM cells, a lymphocyte memory subset that resides in non-lymphoid tissues 2 . T RM cells have been best defined in the CD8 + compartment 2 , but evidence indicates that after local antigen recognition, CD4
+ T cells can also establish transient or permanent residency in non-lymphoid tissues 3, 43 .
However, T H 17-IL-10
+ cells also upregulated their expression of the transcription factor KLF2 and its target gene, S1PR1, whose downregulation in T RM cells is important for promoting the retention of T cells in tissues 2 . It is possible that activated T H 17-IL-10 + cells might represent precursors committed to the T RM cell lineage that, in order to fully differentiate into T RM cells, require additional cues from the tissues that were absent from our in vitro system. Although more work will be needed to define the function of T H 17-IL-10
+ cells in vivo, we are tempted to speculate that after the acute inflammatory response, c-MAF-expressing T H 17 cells might differentiate into T RM cell-like cells and, by extending their residency in tissues, might contribute to the resolution of inflammation through the production of IL-10, the induction of lipid mediators and tissue repair, either directly or through the release of cytokines that induce the differentiation of monocytes into M2 macrophages.
Our study has linked c-MAF to the modulation of a broad immunoregulatory and tissue-residency program in T H 17-IL-10 + cells, which is congruent with its reported role in mediating immunological tolerance in the gut that is dependent on induced T reg cells 44 . That conclusion is supported by the finding that c-MAF bound in the vicinity of a relevant proportion of genes that were expressed differentially in recently activated T H 17 cell subsets and by the finding that the T H 17-IL-10 + cell transcriptional signature was impaired after depletion of c-MAF. Notably, c-MAF did not act as a pioneering transcription factor but exploited a pre-existing enhancer landscape, which would suggest that cooperation with other transcription factors is required. Cooperative binding to regulatory genomic regions might also account for the different transcriptional outcomes of the binding of c-MAF in the vicinity of genes encoding immunoregulatory molecules versus its binding in the vicinity of genes encoding pro-inflammatory molecules, whereby it acted as a co-activator or co-repressor, respectively. In this context, c-MAF shares several features with FOXP3, which has been shown to bind pre-existing active enhancer elements 45 in the vicinity of genes that are over-or under-expressed in T reg cells relative to their expression in memory T cells and whose transcriptional activity depends on the interacting partners 46 . Identification of the transcriptional regulators that act together with c-MAF would allow deeper understanding of the molecular mechanisms underlying the heterogeneity of T H 17 cells.
Our findings obtained with human memory T H 17 cells are in line with the established role of c-MAF in controlling IL-10 production in various helper T cell subsets [9] [10] [11] . A published study has shown that in mouse models of disease related to T H 1 cells and T H 2 cells, deletion of c-Maf that leads to reduced production of IL-10 is accompanied by enhanced inflammation 47 . In contrast, in the T H 17 cell model of experimental autoimmune encephalomyelitis, deletion of c-Maf results in diminished disease severity due to the ability of c-MAF to negatively regulate Il2, which results in increased differentiation into T H 17 cells and decreased differentiation into T reg cells. We also found that c-MAF negatively regulated IL2 expression in already differentiated human memory T H 17-IL-10 + cells; this effect, however, was transient and dependent on the T cell activation state. Thus, c-MAF might regulate T cell function at the priming phase as well as at the effector phase. Together these data are consistent with positive, negative and context-specific effects of c-MAF on T cell differentiation and function.
Although the main focus of our study was the characterization of immunoregulatory T H 17-IL-10 + cells, our findings have also defined previously unknown properties of pro-inflammatory T H 17 cells.
After stimulation via the T cell antigen receptor, pro-inflammatory T H 17 cells had high expression of CCR7, which might drive these cells out of inflamed tissues into lymphatics or into tertiary lymphoid tissues 28, 48 . In addition, these cells induced the polarization of monocytes into M1 macrophages, which, by producing IL-1β and TNF, can suppress IL-10 production by T cells 8, 20 and potentially enable a self-sustaining paracrine circuit that could establish and maintain an inflammatory environment.
While we have shown that the pro-inflammatory and immunoregulatory phenotypes were a stable feature of two circulating subsets of memory T H 17 cells, these cells are not fixed and maintain a considerable level of plasticity, at least in vitro. IL-10-producing T H 17 cells can be converted into pro-inflammatory T H 17 cells by exposure to IL-1β and TNF, which irreversibly switches off IL-10 production while increasing production of IFN-γ and GM-CSF 8, 49 . [50] [51] [52] . T H 17 cells are known to have an important role in host defense against fungi and extracellular bacteria and in the maintenance of gut homeostasis [53] [54] [55] [56] , but they are also involved in tissue inflammation and autoimmune diseases, such as multiple sclerosis, inflammatory bowel disease, psoriasis and rheumatoid arthritis [57] [58] [59] [60] [61] [62] . The pathogenic role of T H 17 cells and other IL-17-producing cells remains to be fully elucidated to help explain the finding that therapies based on antibodies to IL-17 are efficacious in some autoimmune diseases but ineffective or even detrimental in others 63 . The identification of two subsets of T H 17 cells with programmed opposing post-activation fates provides a new paradigm for investigation of the role of these cells in physiology and immunopathology.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41590-018-0200-5. 
Monocyte differentiation. CD14
+ monocytes were sorted from PBMCs by a magnetic system. 1 × 10 5 monocytes were co-cultured for 24 h or 48 h in flatbottomed 96-well plates with 5 × 10 4 allogeneic day 5 (activated) T H 17-IL-10 + or T H 17-IL-10 -cells in 100 μ l complete medium plus 100 μ l supernatant from day 5 (activated) T H 17 cells. Alternatively, 1 × 10 6 CD14 + monocytes were cultured for 7 d in in 24-well plates in the presence of supernatants from day 5 (activated) T H 17-IL-10 + or T H 17-IL-10 -cells (500 μ l complete medium + 500 μ l supernatant). After 48 h, 500 μ l of T H 17 cell-conditioned medium was added to the culture, and 700 μ l supernatant was replaced every 2 d with fresh supernatant. On day 7, monocytes were washed twice to remove non-adherent cells and were stimulated with 10 ng/ ml LPS (TLRgrade, Alexis Biochemicals) for 4 h and 24 h. In parallel, CD14 + monocytes were polarized in vitro into M1 or M2 macrophages by recombinant cytokines as follows: M1, GM-CSF (5 ng/ml) plus IFN-γ (50 ng/ml); M2, M-CSF (20 ng/ml) plus IL-4 (20 ng/ml) plus IL-10 (20 ng/ml) plus TGF-β (4 ng/ml). Gene-expression analysis. Total RNA was extracted from at least 1 × 10 6 cells using the E.Z.N.A. Total RNA Kit I (Omega Bio-tek), according to the manufacturer's instructions. The eluted RNA was incubated at 65 °C for 10 min to resolve secondary structures before the cDNA synthesis and was quantified by the NanoDrop 2000c (Thermo Scientific). cDNA was synthesized using qScript cDNA SuperMix (Quanta Biosciences) according to the manufacturer's instructions. Relative gene expression was measured by qPCR with KAPA SYBR FAST qPCR master mix (Kapa Biosystems) on an ABI PRISM 7900HT Fast System (Applied Biosystems) and was normalized to expression of the control gene TBP (which encodes TATA-binding protein). Primer specificity was validated by a single-peak dissociation-curve profile.
RNA sequencing. RNA sequencing of T H 17-IL-10
+ and T H 17-IL-10 -clone pools was conducted by the Genomics Platform of the Broad Institute in compliance with the institutional review board of Brigham and Women's Hospital (IRB protocol 2014P000124/BWH to H.L.W.). In brief, 250 ng for each sample of total RNA isolated from T cell clone pools with the E.Z.N.A. Total RNA kit I (Omega Bio-tek) was submitted to the Genomics Platform for high coverage (50 million paired-end reads), Tru-Seq standard, strand-specific RNA sequencing. RNA-seq reads generated by the Genomics Platform were quality checked and processed with Tuxedo RNA-Seq pipeline 64 to align reads to human genome assembly GRCh37 and quantify transcripts. Two different gene datasets were extracted from the RNA-seq data that referred to 63,809 genes: a protein-coding dataset, and a lncRNA dataset. GENCODE v19 annotation was used to filter the data (gencode. v19.chr_patch_hapl_scaff.annotation.gtf, available at http://www.gencodegenes. org/). For the protein-coding set, we excluded from the list those genes annotated as mitochondrial genes, genes encoding T cell antigen receptors, pseudogenes and non-protein-coding transcripts. This resulted in a protein-coding set of 23,744 genes. Comparison of gene expression was performed by analysis of fragments per kilobase of exon per million fragments mapped (FPKM) values. Differentially expressed genes were defined using the ratio of changes detected ('fold' values: IL-10 + /IL-10 -) for two donors. Genes with a mean ratio ≥ 2 or ≤ 0.5 were considered (ratio, ≥ 1.8 or ≤ 0.555 in the two independent experiments). From this filtered list, only the genes with a mean FPKM value of ≥ 2 for IL-10 + or IL-10 -were considered. To select specifically expressed lncRNA genes, we first select the transcripts annotated as 'lincRNA' , 'sense_intronic' , 'antisense' and 'nonsense_ mediated_decay' . In total, 14,035 transcripts were identified as lncRNA elements. As previously described, only the differentially expressed transcripts were selected. All measurements were log 2 -transformed, and a visual representation of differential gene expression was generated with MA plots. Genes with a log 2 mean ratio between -10 and 10 and a mean expression above 1 are presented (10,657, 'day 0'; 10,626, 'day 0 + 2 h'; 11,081, 'day 5'; and 10,899, 'day 5 + 2 h'). Each lncRNA was associated to the proximal protein-coding gene, regardless of its transcriptional sense, for gene-ontology (GO) enrichment analysis for biological process terms. Metacore software (Thomson Reuters) was used for the GO analyses. The top 20 (or top 10) ranked GO biological process terms were selected according to their P value. GO terms were then clustered on the basis of their semantic similarity analysis by the G-SESAME tool ('gene semantic similarity analysis and measurement') 18 . This analysis results in a symmetric matrix in which each value represents a score for similarity between GO term pairs. To group all GO terms with the common GO parent, the G-SESAME semantic similarity matrices were subjected to a hierarchical clustering using the heatmap.2 function of the 'gplots' package in R software(Euclidean metric and complete aggregation method).
RNA sequencing of T H 17-IL-10
+ cells depleted of c-MAF was conducted by IGA Technology Services with the same protocols and analysis pipeline. 
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Gene Ontology (GO) analyses on differentially expressed genes from RNA-seq datasets were performed using the MetaCore software (Thomson Reuters). GO terms were then clustered based on their semantic similarity analysis by G-SESAME tool (DOI: 10.1093/nar/ gkp463). To group all GO terms with the common GO parent, the G-SESAME semantic similarity matrices were subjected to a hierarchical clustering using the heatmap.2 function from 'gplots' package in R (https://CRAN.R-project.org/package=gplots).
Gene set enrichment analysis was performed by the GSEA 3.0 analysis tool (DOI: 10.1073/pnas.0506580102; http:// software.broadinstitute.org/gsea/) and gene expression data were processed and visualized with GENE-E (https://software. broadinstitute.org/GENE-E/) and Morpheus (https://software.broadinstitute.org/morpheus/). For the generation of consistent gene identifiers across datasets to use in GSEA analysis the DAVID Gene ID Conversion Tool was used (DOI: 10.1038/nprot.2008.211; https:// david.ncifcrf.gov/conversion.jsp).
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ChIP-seq data analysis was performed using the Fish the ChIPs software (DOI: 10.1186/1745-6150-6-51) and visualized through the Integrative Genomics Viewer v2.3.97 (https://www.broadinstitute.org/igv/). c-MAF ChIP-seq peaks were associated to genes by proximity through the GREAT (version 3.0) web-based software (DOI: 10.1038/ nbt.1630; http://great.stanford.edu/public/html/). H3K27ac distribution in proximity to c-MAF peaks and the nucleosome-free regions (NFR) from H3K27ac ChIP-seq datasets were computed with Homer v.4.9.1 (DOI: 10.1016/j.molcel.2010.05.004; http://homer.ucsd.edu/homer/). NFRs that overlapped or resided in proximity to H3K27ac peaks were identified with Bedtools (version 2.25.0) (http://bedtools.readthedocs.io/en/latest/index.html#).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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There are no restrictions of unique materials. The datasets generated during the current study will be available in the GEO Dataset repository before publication.
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